Narus Financial Partners LLC lessened its holdings in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 25.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 7,073 shares of the enterprise software provider's stock after selling 2,471 shares during the period. Narus Financial Partners LLC's holdings in Oracle were worth $989,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in ORCL. Harel Insurance Investments & Financial Services Ltd. increased its stake in Oracle by 71.6% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock valued at $35,984,000 after acquiring an additional 107,404 shares during the period. Rockland Trust Co. increased its stake in Oracle by 4.8% during the first quarter. Rockland Trust Co. now owns 10,165 shares of the enterprise software provider's stock valued at $1,421,000 after acquiring an additional 467 shares during the period. Calamos Advisors LLC increased its stake in Oracle by 1.5% during the first quarter. Calamos Advisors LLC now owns 711,290 shares of the enterprise software provider's stock valued at $99,445,000 after acquiring an additional 10,426 shares during the period. Cornerstone Advisory LLC increased its stake in Oracle by 34.1% during the fourth quarter. Cornerstone Advisory LLC now owns 12,968 shares of the enterprise software provider's stock valued at $2,258,000 after acquiring an additional 3,299 shares during the period. Finally, Peak Retirement Planning Inc. bought a new stake in shares of Oracle in the 4th quarter valued at approximately $211,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Insider Buying and Selling at Oracle
In other Oracle news, Director Rona Alison Fairhead acquired 480 shares of the company's stock in a transaction that occurred on Monday, July 7th. The shares were acquired at an average price of $233.87 per share, with a total value of $112,257.60. Following the purchase, the director owned 22,110 shares of the company's stock, valued at $5,170,865.70. This represents a 2.22% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $190.42, for a total value of $76,168,000.00. Following the completion of the sale, the insider directly owned 1,097,576 shares in the company, valued at $209,000,421.92. This represents a 26.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 445,366 shares of company stock worth $84,784,653 in the last three months. 42.20% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on ORCL. KeyCorp upped their price objective on Oracle from $200.00 to $225.00 and gave the company an "overweight" rating in a research note on Thursday, June 12th. Guggenheim upped their price objective on Oracle from $220.00 to $250.00 and gave the company a "buy" rating in a research note on Wednesday, June 18th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 price objective (up from $200.00) on shares of Oracle in a research note on Thursday, June 12th. Stifel Nicolaus upgraded Oracle from a "hold" rating to a "buy" rating and upped their price objective for the company from $180.00 to $250.00 in a research note on Monday, June 30th. Finally, Jefferies Financial Group upped their price objective on Oracle from $190.00 to $200.00 and gave the company a "buy" rating in a research note on Monday, June 9th. Nine analysts have rated the stock with a hold rating, twenty-three have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $209.33.
Get Our Latest Analysis on ORCL
Oracle Trading Down 1.9%
Shares of ORCL stock traded down $4.55 during trading hours on Friday, reaching $230.45. The company had a trading volume of 10,172,356 shares, compared to its average volume of 10,270,690. The company has a 50 day moving average of $187.16 and a 200 day moving average of $166.42. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. The firm has a market cap of $647.29 billion, a price-to-earnings ratio of 53.10, a P/E/G ratio of 3.45 and a beta of 1.39. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $241.44.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion for the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The firm's revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.63 EPS. On average, equities research analysts anticipate that Oracle Corporation will post 5 EPS for the current year.
Oracle Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.87%. The ex-dividend date is Thursday, July 10th. Oracle's payout ratio is presently 46.08%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report